The objective of this study was to examine the differences in oscillatory brain dynamics in Alzheimer's disease (AD) according to age at onset using quantitative electroencephalography (EEG). We examined resting state electroencephalograms of 320 probable AD patients and 246 controls, both categorized into a young (Յ 65 years) and old (Ͼ 65 years) group. Relative power in 4 different frequency bands was calculated. The effect of age on global and regional relative power was examined. Globally, young AD patients showed lower alphaand higher delta-power than old AD patients. Regional analysis showed that these differences were most pronounced in the parieto-occipital region. Young AD patients had lower beta-and higher theta-power than old patients in all but the temporal regions. In controls, there was no age effect on global relative power in any frequency band. Young AD patients present with more severe slowing of spontaneous oscillatory activity than old AD patients, which is most pronounced in the posterior brain areas. This finding supports the hypothesis that early onset AD presents with a distinct endophenotype.
Introduction
Large-scale neuronal activity can be measured with electroencephalography (EEG). The hallmark oscillatory brain dynamics finding in Alzheimer's disease (AD) patients is a diffuse slowing of activity (Jeong, 2004) , with a decrease in alpha power and an increase in delta power Bennys et al., 2001; Moretti et al., 2004) . In addition, a reduced reactivity of alpha power on eye opening has been reported in mild AD patients (Babiloni et al., 2010) . However, within the spectrum of AD there is a large variation in severity of EEG abnormalities. In a former study in our memory clinic cohort, visually rated EEG in AD patients varied from a completely normal EEG to a combination of both focal and diffuse abnormalities (Liedorp et al., 2009) .
There is a growing body of evidence suggesting that age at onset is related to manifestation of the disease. Differences between young and old patients may point at different underlying disease pathways. Understanding these different pathways may provide new targets for treatment. Young patients have a clinical profile with more focal disturbances like aphasia and apraxia, in contrast to old patients where memory impairment is most pronounced (Greicius et al., 2002; Koedam et al., 2010; Licht et al., 2007; Seltzer and Sherwin, 1983; van der Vlies et al., 2009 ). In addition, young patients often show a different pattern of atrophy, with posterior regions being more affected (Frisoni et al., 2007; Karas et al., 2007) . In a recent study, we assessed the influence of age at onset on EEG abnormalities. Severity of EEG abnormalities was rated on a simple, 4-point scale ranging from no abnormalities to severe abnormalities. We found that young AD patients had more frequent and severe EEG abnormalities than old AD patients (de Waal et al., 2011) . In this study we did not quantify the abnormalities, nor could we say anything about regional distribution. Using quantitative EEG, a higher power in the theta band and a more "abnormal" EEG with a younger age at onset has been reported, but only in small samples or using only a few electrode positions (Pucci et al., 1999; Schreiter-Gasser et al., 1994) .
In the present study we used quantitative EEG to compare severity and location of oscillatory brain dynamics changes in a large sample of young and old AD patients and controls in order to gain more insight in the heterogeneity of pathophysiological differences within Alzheimer's disease. We hypothesize that young AD patients will have a different regional vulnerability than old AD patients, with more severe slowing in the posterior brain regions.
Methods

Subjects
We included 320 AD patients and 246 controls. All patients had been referred to the memory clinic of the Alzheimer center of the VU University Medical Center, Amsterdam, the Netherlands between September 2003 and June 2009. Standardized dementia screening included a history and, when available, an informant-based history, a standard neurological examination, a cognitive examination including Mini Mental State Examination (MMSE), EEG, magnetic resonance imaging (MRI) of the brain, neuropsychological evaluation, and laboratory tests. Patients were diagnosed with probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria during a multidisciplinary consensus meeting (McKhann et al., 1984) . The control group consisted of patients who presented at our memory clinic with subjective complaints, but who had normal clinical investigations and did not have significant cognitive deficits (i.e., mild cognitive impairment [MCI] criteria were not fulfilled) or major psychiatric disorder. Both groups were categorized in young (65 years or younger; AD, n ϭ 113; controls, n ϭ 174) and old (older than 65 years; AD, n ϭ 207; controls, n ϭ 72). The ethical review board of the VU University Medical Center has approved the study. All patients gave written informed consent to use their clinical data for research purposes.
EEG recording
All EEGs were recorded using the OSG digital equipment (Brainlab; OSG b.v., Rumst, Belgium) from 21 electrodes at the positions of the 10 -20 system: Fp2, Fp1, F8, F7, F4, F3, A2, A1, T4, T3, C4, C3, T6, T5, P4, P3, O2, O1, Fz, Cz, Pz, with an average reference which included all electrodes, except Fp2, Fp1, A2, and A1. Sample frequency was 500 Hz. Electrode impedance was below 5 k⍀. Initial filter settings were time constant 1 second; low pass filter, 70 Hz. Patients were seated in a slightly reclined chair in a sound attenuated room. Patients sat mainly with eyes closed, EEG technicians were alert on keeping patients awake by sound stimuli.
Four 10-second epochs of artifact free data (containing no eye blinks, slow eye movements, excess muscle activity, electrocardiogram [ECG] artifacts, etc.) were selected from each EEG (HdW). Relative power of all frequency bands (delta 0.5-4 Hz, theta 4 -8 Hz, alpha 8 -13 Hz, beta 13-30 Hz, and gamma 30 -48 Hz) was calculated for all EEG channels using Fast Fourier Transformation. A flat window was applied over the full 4096 samples of each epoch. The power in the frequency bands of interest was determined by averaging over the 4 epochs (with Brain wave software, version 0.8.60, developed by C.J.S.; further information: home.kpn.nl/ stam7883/brainwave.html). By averaging the relative power of all electrodes a mean relative power for each frequency band was obtained. Our group used this method in previous studies. Gamma band was not included in further analyses, because of the possible admixture of muscle artifacts in this frequency band (Whitham et al., 2007 (Whitham et al., , 2008 . Channels were clustered into 4 regions of interest: frontal, temporal, central, and parieto-occipital. The frontal cluster was formed by channels Fp1, Fp2, F7, F8, F3, F4, and Fz; the temporal cluster was formed by channels A1, A2, T3, T4, T5, and T6; the central cluster was formed by channels C4, C3, and Cz; and the parieto-occipital cluster was formed by channels P3, P4, Pz, O1, and O2. For further statistical analysis the mean relative power values were log transformed (x ϭ log [x/1Ϫx]) to obtain a more Gaussian distribution (Gasser et al., 1982) .
Statistics
PASW Statistics 18.0 for Mac (IBM Corp, Armonk, NY, USA) was used for statistical analyses. Differences between groups for baseline characteristics were investigated with t-tests and 2 -tests where appropriate. First, the effect of age (young vs. old) on relative power was tested in both AD patients and controls, for each frequency band separately, using 2-way analysis of variance (ANOVA). The mean relative power was used as dependent variable, age (young vs. old), and diagnosis were entered in the model as binary fixed factors, sex was entered as covariate. Secondly, the effect of age on relative power in different brain regions was examined, using ANOVA for repeated measures. Age was used as between-subjects factor and brain area (4 regions: frontal, temporal, central, and parieto-occipital) was used as within-subjects factor. Relative power was the dependent variable. Sex was entered as covariate. Separate models for each frequency band were used; analyses were done separately for AD patients and controls.
Results
Baseline characteristics are summarized in Table 1 . The young AD group was on average a few years older than the young control group (p Ͻ 0.05) and the old AD group was also a few years older than the old controls (p Ͻ 0.05). The young and old AD patients had comparable gender distribution, MMSE, and disease duration. In the young and old AD group a comparably small percentage of patients used acetylcholinesterase inhibitors.
We used 2-way ANOVA to assess the effect of age on the global power spectrum in AD patients and controls. Global relative power values for AD and controls stratified by age are given in Table 1 . There was a main effect of diagnosis in all frequency bands (alpha: F(1,561) ϭ 64.03; p Ͻ 0.001; beta: F(1,561) ϭ 36.07; p Ͻ 0.001; theta: F(1,561) ϭ 162.72; p Ͻ 0.001; delta: F(1,561) ϭ 14.61; p Ͻ 0.001), as AD patients had a higher delta and theta and lower alpha and beta power than controls. In the alpha and delta band we found a main effect of age (alpha: F(1,561) ϭ 12.16; p ϭ 0.001; delta: F(1,561) ϭ 15.40; p Ͻ 0.001) and an interaction between age and diagnosis (alpha: F(1,561) ϭ 4.25; p ϭ 0.040; delta: F(1,561) ϭ 3.60; p ϭ 0.58). Young AD patients had a lower global alpha power and higher delta power than old AD patients, whereas in controls there were no differences between the young and old. In the beta and theta band no age effects or interactions were found. When we repeated the analyses after exclusion of acetylcholinesterase inhibitor users, the results did not change essentially, except for the interaction between age and diagnosis in the alpha band, which lost significance.
Subsequently, we explored regionally specific effects of age in AD patients and controls separately using ANOVA for repeated measures (Fig. 1, Table 2 ). For AD patients there was a main effect of age (F(1,317) ϭ 19.59; p Ͻ 0.001) and area (F(2.78,881.30) ϭ 3.83; p ϭ 0.012) and an interaction between age and area (F(2.78,881.30) ϭ 3.83; p ϭ 0.012) in the alpha band. We found a lower relative power in young AD patients as compared with old patients in all brain regions, but the difference between young and old patients was largest in the parieto-occipital region. In the beta band, there was no main effect of age, but there was a main effect of area (F(2.82,893.83) ϭ 30.76; p Ͻ 0.001) and an interaction between age and area (F(2.82,893.83) ϭ 3.58; p ϭ 0.016). Young AD patients had a lower relative power than old patients in the frontal, central, and parieto-occipital region, while old patients had lower relative power in the temporal regions. In the theta band, there was no main effect of age, but there was a main effect of area (F(2.83,897.25) ϭ 6.26; p Ͻ 0.001) and an interaction between age and area (F(2.83,897.25) ϭ 6.92; p Ͻ 0.001), which mirrored the pattern observed in the beta band. Young AD patients had a higher relative theta power in the in the frontal, central, and parieto-occipital regions, but old patients had a higher relative power in the temporal regions. In the delta band, there were main effects of age (F(1,317) ϭ 19.392; p Ͻ 0.001) and area (F(2.87,910.48) ϭ 35.38; p Ͻ 0.001) and an interaction between age and area (F(2.87,910.48) ϭ 4.43; p ϭ 0.005). Young AD patients had a higher relative delta power than old AD patients, which was most pronounced in the frontal and parietooccipital regions. When we repeated the analyses after exclusion of acetylcholinesterase inhibitor users, the results did not change essentially.
For controls, there was a main effect of area (alpha: F(2.66,645.63) ϭ 26.35; p Ͻ 0.001; delta: F(2.68,650.75 ) ϭ 39.29; p Ͻ 0.001), but no main effect of age nor an interaction between age and area in the alpha and 1008.e28delta band. In the beta band there was no main effect of age, but there was a main effect of area (F(2.89,701.97) ϭ 34.79; p Ͻ 0.001) and an interaction between age and area (F(2.89,701.97) ϭ 11.41; p Ͻ 0.001). Old controls had lower beta power in the temporal and parieto-occipital regions than young controls, while such an effect was not observed in other brain regions. In the theta band there was no main effect of age, but there was a main effect of area (F(2.94,714.42) ϭ 9.33; p Ͻ 0.001) and an interaction between age and area (F(2.94,714.42) ϭ 8.93; p Ͻ 0.001). Old controls had higher theta power than young controls in all regions, except for the central region, where there was no difference between groups.
Discussion
The main finding of this study is that young AD patients had relatively less power in the faster alpha band and more power in the slower delta band than old AD patients and that this difference was greatest in the posterior regions. Moreover, in the beta band and theta band we also found a different regional distribution between young and old AD patients. In controls, there was no difference in global relative power between age groups. We did find some specific regional differences between young and old controls in the beta and theta band, but these were smaller than the differences in AD.
Previous EEG studies have shown a decrease of power in the fast frequency bands and increase of power in slower frequency bands in AD patients compared with controls Bennys et al., 2001; Jeong, 2004; Moretti et al., 2004) . We confirm these former findings as the entire group of AD patients had more delta and theta power and less alpha and beta power than controls. Variability in severity of EEG abnormalities in AD has been shown before. In a study including 35 AD patients and 35 controls, quantitative EEG discriminated between patients and controls, but within the group of AD patients there was a large, unexplained, variation in the ratios between fast and slow activity (Bennys et al., 2001) . In a former study on EEG in a memory clinic population, we found that AD patients more often show EEG abnormalities than nondemented individuals. Within the group of AD patients however, EEGs ranged from completely normal to both focal and diffuse abnormalities (Liedorp et al., 2009) . As yet, it remains unclear what causes this heterogeneity. Severity of the disease and the use of acetylcholinesterase inhibitors have been found to influence these differences (Gianotti et al., 2008; Rodriguez et al., 2002; van der Hiele et al., 2007) , but this does not explain the entire picture.
In the current study, we focused on age at onset as a determinant of severity and distribution of oscillatory brain dynamics. Our findings are in line with the few previous studies on quantitative EEG analysis in young and old AD patients (Duffy et al., 1984; Matousek et al., 2001; Miyauchi et al., 1994; Pucci et al., 1999; Schreiter-Gasser et al., 1994) . In a study using visual classification of power spectra, a more abnormal EEG was correlated with a younger age of onset, but regional differences were not taken into account (Pucci et al., 1999) . In a very small cohort of 9 young and 10 old AD patients compared with healthy con- trols, maximal group differences between young AD patients and controls were found in the right posterior temporal lobe, whereas maximal group differences between old AD patients and their controls were found in the midfrontal and bilateral anterior areas (Duffy et al., 1984) . A direct comparison between early onset and late onset AD was not made however. We found more slowing (relatively less alpha and more delta power) in young than in old AD patients. Moreover, we observed a different regional distribution of EEG abnormalities, with relatively more disturbed activity in the parieto-occipital regions in young AD, while in old AD patients activity was relatively more disturbed in the temporal regions. A study using source localization has provided evidence that EEG findings are a marker of underlying brain pathology (Prichep, 2007) . Furthermore, these findings coincide with results from studies in other modalities and suggest a different regional vulnerability in young onset patients. AD is typically characterized by memory impairment accompanied by atrophy of the medial temporal lobe. In patients with early onset however, the cognitive profile is often dominated by nonmemory problems such as apraxia, aphasia, and visuospatial dysfunction, and atrophy is often observed in parietal and posterior brain regions (Frisoni et al., 2005; Ishii et al., 2005; Karas et al., 2007; Koedam et al., 2010; Shiino et al., 2006; Snowden et al., 2007; Suribhatla et al., 2004) . Furthermore, in early onset AD reduced metabolism has been found in the parietal and posterior association cortices (Kemp et al., 2003; Kim et al., 2005; McMurtray et al., 2008; Nitrini et al., 2000; Rabinovici et al., 2010; Sakamoto et al., 2002) .
Strengths of the present study are the large population of consecutive patients and controls, who all received an EEG as part of the standard work-up. We measured relative power, a well-known measure of quantitative EEG analysis, which allowed us to study regional changes in oscillatory brain activity in a reliable and detailed way. Possible limitations are the fact that we used persons with subjective complaints as control group, as these patients are known to have an increased risk of progression to dementia. The main question in this study involved a comparison between early and late onset AD however, which is not influenced by the control group.
In this study we focused on regional differences in oscillatory activity between early and late onset AD. Regional analyses do not take into account connections between neurons. AD has been termed a disconnection syndrome, with evidence for disrupted functional and structural connectivity in AD patients (Delbeuck et al., 2003; He et al., 2009) . Future studies should focus on functional networks, as it can be hypothesized that these networks are differentially compromised in early onset and late onset AD.
In conclusion, we found that young AD patients present with more severe slowing of spontaneous oscillatory activity than old AD patients, which is most pronounced in the posterior brain areas. This finding supports the hypothesis that early onset AD presents with a distinct endophenotype. A picture emerges that there may be different pathways leading to AD in young and old patients. These pathways may in turn be linked to differences in prognosis and response to therapy. Furthermore, the biological underpinnings of differences between old and young patients may lead to new targets for therapy.
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